$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 18 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 16.02 | 42,979 | 688,524 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 15.03 | 33,593 | 504,903 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 13.05 | 34,514 | 450,408 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 18.01 | 6,032 | 108,636 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 16.02 | 7,021 | 112,476 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 15.03 | 6,407 | 96,297 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 13.05 | 25,486 | 332,592 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 1,360 | 42,160 | 0 | 1.4 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 1,360 | 42,160 | 1,360 | 2.7 K to 1.4 K (-50.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 1,799 | 55,769 | 2,720 | 4.5 K to 2.7 K (-39.81 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 453 | 14,043 | 0 | 453 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 885 | 27,435 | 453 | 1.3 K to 453 (-66.14 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 39,917 | 1,237,427 | 0 | 39.9 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 0.00 | 35,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | H | 41.34 | 14,320 | 591,989 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | H | 36.90 | 12,516 | 461,840 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 24.87 | 16,027 | 398,591 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 22.60 | 144 | 3,254 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 18.85 | 833 | 15,702 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 18.01 | 19,340 | 348,313 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 16.54 | 2,930 | 48,462 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 16.02 | 123,758 | 1,982,603 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 15.03 | 113,027 | 1,698,796 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 9.02 | 13,748 | 124,007 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | H | 41.34 | 3,680 | 152,131 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | H | 36.90 | 1,484 | 54,760 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 24.87 | 3,973 | 98,809 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 22.60 | 937 | 21,176 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 19.79 | 1,208 | 23,906 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 18.01 | 7,360 | 132,554 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 16.54 | 2,633 | 43,550 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 16.02 | 6,242 | 99,997 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 15.03 | 11,973 | 179,954 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Option Exercise | J | 9.02 | 6,252 | 56,393 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Sell | J | 31.00 | 3,159 | 97,929 | 0 | 3.2 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Sell | J | 31.00 | 4,815 | 149,265 | 3,159 | 8 K to 3.2 K (-60.38 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Sell | J | 31.00 | 359 | 11,129 | 0 | 359 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Sell | J | 31.00 | 886 | 27,466 | 0 | 886 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Sell | J | 31.00 | 453 | 14,043 | 886 | 1.3 K to 886 (-33.83 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Sell | J | 31.00 | 1,012 | 31,372 | 0 | 1 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Weyer Christian | SVP, Research & Dev ... | Sell | J | 31.00 | 33,195 | 1,029,045 | 1,012 | 34.2 K to 1 K (-97.04 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 0.00 | 35,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | H | 41.34 | 52,582 | 2,173,740 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | H | 36.90 | 67,289 | 2,482,964 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 24.87 | 60,980 | 1,516,573 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 22.60 | 60,576 | 1,369,018 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 18.85 | 57,243 | 1,079,031 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 18.01 | 53,356 | 960,942 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 16.54 | 58,838 | 973,181 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 16.02 | 42,099 | 674,426 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 15.03 | 19,781 | 297,308 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 9.02 | 42,186 | 380,518 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 41.34 | 2,418 | 99,960 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | H | 36.90 | 2,711 | 100,036 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 24.87 | 4,020 | 99,977 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 22.60 | 4,424 | 99,982 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 18.85 | 7,757 | 146,219 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 18.01 | 6,644 | 119,658 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 16.54 | 6,162 | 101,919 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 16.02 | 7,901 | 126,574 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 15.03 | 5,219 | 78,442 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 2,990 | 92,690 | 0 | 3 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 4,984 | 154,504 | 2,990 | 8 K to 3 K (-62.50 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 12,767 | 395,777 | 0 | 12.8 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 415 | 12,865 | 0 | 415 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 192,146 | 5,956,526 | 415 | 192.6 K to 415 (-99.78 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | J | 31.00 | 71,349 | 2,211,819 | 192,561 | 263.9 K to 192.6 K (-27.04 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | J | 31.00 | 71,349 | 2,211,819 | 263,910 | 192.6 K to 263.9 K (+37.05 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 0.00 | 25,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | H | 41.34 | 32,415 | 1,340,036 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | H | 36.90 | 57,289 | 2,113,964 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 24.87 | 65,980 | 1,640,923 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 18.01 | 63,252 | 1,139,169 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 16.54 | 2,956 | 48,892 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 16.02 | 91,621 | 1,467,768 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 15.03 | 62,467 | 938,879 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 9.02 | 51,561 | 465,080 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | H | 41.34 | 2,585 | 106,864 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | H | 36.90 | 2,711 | 100,036 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 24.87 | 4,020 | 99,977 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 18.01 | 6,748 | 121,531 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 16.80 | 23,064 | 387,475 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 16.54 | 344 | 5,690 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 16.02 | 8,379 | 134,232 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 15.03 | 7,533 | 113,221 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Option Exercise | J | 9.02 | 3,439 | 31,020 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Sell | U | 31.00 | 1,360 | 42,160 | 0 | 1.4 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Sell | U | 31.00 | 6,614 | 205,034 | 1,360 | 8 K to 1.4 K (-82.94 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Sell | U | 31.00 | 473 | 14,663 | 0 | 473 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Sell | U | 31.00 | 2,136 | 66,216 | 473 | 2.6 K to 473 (-81.87 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Sell | J | 31.00 | 53,181 | 1,648,611 | 0 | 53.2 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Buy | J | 31.00 | 53,181 | 1,648,611 | 53,181 | 0 to 53.2 K |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Sell | U | 31.00 | 412 | 12,772 | 0 | 412 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | SVP, Corporate Deve ... | Sell | U | 31.00 | 64,338 | 1,994,478 | 412 | 64.8 K to 412 (-99.36 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | J | 0.00 | 3,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | J | 0.00 | 11,021 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | J | 0.00 | 11,573 | 0 | 11,021 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | H | 44.64 | 12,000 | 535,680 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | H | 37.18 | 20,000 | 743,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | H | 31.77 | 12,000 | 381,240 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | J | 27.30 | 20,000 | 546,000 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | J | 21.52 | 20,000 | 430,400 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | J | 13.18 | 20,000 | 263,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | J | 11.68 | 20,000 | 233,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Sell | J | 31.00 | 8,000 | 248,000 | 0 | 8 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Option Exercise | H | 46.58 | 20,000 | 931,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Option Exercise | H | 31.77 | 12,000 | 381,240 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Option Exercise | J | 27.30 | 20,000 | 546,000 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Option Exercise | J | 21.52 | 20,000 | 430,400 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Option Exercise | J | 13.18 | 20,000 | 263,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Option Exercise | J | 11.68 | 20,000 | 233,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Sell | J | 31.00 | 10,200 | 316,200 | 0 | 10.2 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Sell | J | 31.00 | 10,800 | 334,800 | 10,200 | 21 K to 10.2 K (-51.43 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | J | 0.00 | 3,273 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | J | 0.00 | 11,971 | 0 | 3,273 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | H | 44.64 | 12,000 | 535,680 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | H | 41.34 | 12,000 | 496,080 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | H | 31.77 | 12,000 | 381,240 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | J | 30.15 | 20,000 | 603,000 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | J | 27.30 | 20,000 | 546,000 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | J | 21.52 | 20,000 | 430,400 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | J | 13.18 | 20,000 | 263,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | J | 11.68 | 20,000 | 233,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Sell | J | 31.00 | 6,000 | 186,000 | 0 | 6 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | J | 0.00 | 3,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | J | 0.00 | 4,015 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | J | 0.00 | 6,173 | 0 | 4,015 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | H | 44.64 | 12,000 | 535,680 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | H | 41.34 | 12,000 | 496,080 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | H | 31.77 | 12,000 | 381,240 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | J | 27.30 | 20,000 | 546,000 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | J | 21.52 | 20,000 | 430,400 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | J | 13.18 | 20,000 | 263,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | J | 11.68 | 20,000 | 233,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Sell | J | 31.00 | 4,580 | 141,980 | 0 | 4.6 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 0.00 | 8,962 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 0.00 | 17,451 | 0 | 8,962 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 0.00 | 260 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | H | 44.64 | 12,000 | 535,680 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | H | 41.34 | 12,000 | 496,080 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | H | 31.77 | 12,000 | 381,240 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 28.60 | 20,000 | 572,000 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 27.30 | 20,000 | 546,000 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 22.89 | 12,000 | 274,680 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 21.52 | 20,000 | 430,400 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 16.23 | 12,000 | 194,760 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 13.18 | 20,000 | 263,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 11.68 | 20,000 | 233,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Sell | J | 31.00 | 6,000 | 186,000 | 0 | 6 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | J | 0.00 | 7,039 | 0 | 0 |